Aperçu des produits pour anti-Glypican 3 (GPC3) Anticorps

Full name:
anti-Glypican 3 Anticorps (GPC3)
Chez www.anticorps-enligne.fr sont 363 Glypican 3 (GPC3) Anticorps de 23 de différents fournisseurs disponibles. De plus, nous expédions Glypican 3 Kits (57) et Glypican 3 Protéines (39) et beaucoup plus de produits pour cette protéine. Un total de 469 Glypican 3 produits sont actuellement listés.
Synonymes:
DGSX, Glypican-3, GPC3, GTR2-2, MXR7, OCI-5, SDYS, SGB, SGBS, SGBS1

Réactivités les plus populaires pour anti-Glypican 3 (GPC3) Anticorps

Sélectionnez vos espèces et l'application

anti-Human Glypican 3 Anticorps:

anti-Mouse (Murine) Glypican 3 Anticorps:

anti-Rat (Rattus) Glypican 3 Anticorps:

Tous anti-Glypican 3 Anticorps disponible

Vous arrivez à notre recherche pré-filtrée.

anti-Glypican 3 Anticorps mieux référencés

  1. Human Polyclonal Glypican 3 Primary Antibody pour EIA, IF - ABIN1449428 : Nakatsura, Kageshita, Ito, Wakamatsu, Monji, Ikuta, Senju, Ono, Nishimura: Identification of glypican-3 as a novel tumor marker for melanoma. dans Clinical cancer research : an official journal of the American Association for Cancer Research 2004 (PubMed)
    Show all 5 references for 1449428

  2. Human Polyclonal Glypican 3 Primary Antibody pour EIA, WB - ABIN952555 : Lai, Oseini, Moser, Yu, Elsawa, Hu, Nakamura, Han, Aderca, Isomoto, Garrity-Park, Shire, Li, Sanderson, Adjei, Fernandez-Zapico, Roberts: The oncogenic effect of sulfatase 2 in human hepatocellular carcinoma is mediated in part by glypican 3-dependent Wnt activation. dans Hepatology (Baltimore, Md.) 2010 (PubMed)
    Show all 5 references for 952555

  3. Human Polyclonal Glypican 3 Primary Antibody pour FACS, ICC - ABIN4899915 : Sawada, Yoshikawa, Nobuoka, Shirakawa, Kuronuma, Motomura, Mizuno, Ishii, Nakachi, Konishi, Nakagohri, Takahashi, Gotohda, Takayama, Yamao, Uesaka, Furuse, Kinoshita, Nakatsura: Phase I trial of a glypican-3-derived peptide vaccine for advanced hepatocellular carcinoma: immunologic evidence and potential for improving overall survival. dans Clinical cancer research : an official journal of the American Association for Cancer Research 2012 (PubMed)
    Show all 3 references for 4899915

  4. Human Polyclonal Glypican 3 Primary Antibody pour IHC (p), WB - ABIN390317 : Boily, Saikali, Sinnett: Methylation analysis of the glypican 3 gene in embryonal tumours. dans British journal of cancer 2004 (PubMed)
    Show all 3 references for 390317

  5. Human Polyclonal Glypican 3 Primary Antibody pour IF, WB - ABIN390319 : Wichert, Stege, Midorikawa, Holm, Lage: Glypican-3 is involved in cellular protection against mitoxantrone in gastric carcinoma cells. dans Oncogene 2004 (PubMed)
    Show all 3 references for 390319

  6. Human Monoclonal Glypican 3 Primary Antibody pour ICC, FACS - ABIN969523 : Zittermann, Capurro, Shi, Filmus: Soluble glypican 3 inhibits the growth of hepatocellular carcinoma in vitro and in vivo. dans International journal of cancer. Journal international du cancer 2010 (PubMed)
    Show all 2 references for 969523

  7. Human Monoclonal Glypican 3 Primary Antibody pour EIA, IF - ABIN1107403 : Takai, Ashihara, Ishiguro, Terashima, Watanabe, Kato, Suzuki: Involvement of glypican-3 in the recruitment of M2-polarized tumor-associated macrophages in hepatocellular carcinoma. dans Cancer biology & therapy 2010 (PubMed)
    Show all 2 references for 1107403

  8. Cow (Bovine) Polyclonal Glypican 3 Primary Antibody pour IHC, WB - ABIN2780199 : Bhave, Mars, Donthamsetty, Zhang, Tan, Luo, Bowen, Michalopoulos: Regulation of liver growth by glypican 3, CD81, hedgehog, and Hhex. dans The American journal of pathology 2013 (PubMed)
    Show all 2 references for 2780199

  9. Human Monoclonal Glypican 3 Primary Antibody pour FACS, ICC - ABIN4899916 : Haupt, Murali, Mun, Teplyuk, Mei, Stein, van Wijnen, Nurcombe, Cool: The heparan sulfate proteoglycan (HSPG) glypican-3 mediates commitment of MC3T3-E1 cells toward osteogenesis. dans Journal of cellular physiology 2009 (PubMed)

Plus d’anticorps contre Glypican 3 partenaires d’interaction

Human Glypican 3 (GPC3) interaction partners

  1. The diagnostic sensitivity for hepatocellular carcinoma increased to 72.8% (206 of the 283) when glypican 3 was combined with alpha-fetoprotein (Montrer AFP Anticorps).

  2. The lncRNA glypican 3 antisense transcript 1 (GPC3-AS1 (Montrer PTGDR Anticorps)) has been reported to be a potential biomarker for hepatocellular carcinoma (HCC (Montrer FAM126A Anticorps)) screening. We observed a significant upregulation of GPC3-AS1 (Montrer PTGDR Anticorps) in HCC (Montrer FAM126A Anticorps). Increased expression of GPC3-AS1 (Montrer PTGDR Anticorps) was associated with alpha-fetoprotein (Montrer AFP Anticorps), tumor size, microvascular invasion, encapsulation, Barcelona Clinic Liver Cancer stage, and worse prognosis of HCC (Montrer FAM126A Anticorps) patients.

  3. study provides the first evidence that GPC3 can modulate the PCSK9 (Montrer PCSK9 Anticorps) extracellular activity as a competitive binding partner to the LDLR (Montrer LDLR Anticorps) in HepG2 cells.

  4. By subsequent Sanger sequencing of genomic DNA we could map the chromosomal break points to define a deletion size of 43,617 bp including exons 5 and 6 of the GPC3 gene.

  5. This is the first study in which the optimal HLA-A*0201 GPC3 epitopes were screened from a large number of candidates predicted by three software. The optimized HLA-A*0201 GPC3 peptides will provide new epitope candidates for hepatocellular carcinoma (HCC (Montrer FAM126A Anticorps)) immunotherapy.

  6. GPC3 and KRT19 (Montrer KRT19 Anticorps) overexpression are associated with carcinogenesis, progression, and poor prognosis in patients with PDAC and a valuable biomarker for diagnosis of PDAC.

  7. The clinical implication of GPC3 detection and targeting in the management of patients with hepatocellular carcinoma. Review.

  8. Glypican 3 expression showed a significant difference between endometrioid endometrial carcinoma and serous endometrial carcinoma, and it was significantly correlated with tumor grade, stage and myometrial invasion

  9. Data show that notum (Montrer NOTUM Anticorps) and glypican-1 (Montrer GPC1 Anticorps) and glypican-3 gene expression during colorectal cancer (CRC (Montrer CALR Anticorps)) development and present evidence to suggest them as potential new biomarkers of CRC (Montrer CALR Anticorps) pathogenesis.

  10. GPC3 expression was measured in hepatocellular carcinoma at different stages and correlated with prognosis. CK19 (Montrer KRT19 Anticorps)+/GPC3+ HCC (Montrer FAM126A Anticorps) has the highest risk of intrahepatic metastasis, microvascular invasion, regional lymph node involvement, and distant metastasis.

Mouse (Murine) Glypican 3 (GPC3) interaction partners

  1. Data show that notum (Montrer NOTUM Anticorps) and glypican-1 (Montrer GPC1 Anticorps) and glypican-3 gene expression during colorectal cancer (CRC (Montrer SCRIB Anticorps)) development and present evidence to suggest them as potential new biomarkers of CRC (Montrer SCRIB Anticorps) pathogenesis.

  2. Coupling of pGPC3 to liposomes was essential for effective priming of GPC3-specific CTLs.

  3. The expression of GPC-3 was altered by DEN treatment.

  4. Data suggest that GPC3 down-regulates hepatocyte proliferation by binding to hedgehog (Montrer SHH Anticorps) (HH) and down-regulating the HH signaling pathway and binding with CD81 (Montrer CD81 Anticorps), thus making it unavailable to bind to Hhex (Montrer HHEX Anticorps) and causing its nuclear translocation.

  5. Finding represents a rare four layer genomic overlap consisting of growth associated quantitative trait locus (QTL), body mass associated Gpc3 gene, highly conserved miRNA gene and mature miRNA seed SNP identified in the lean mouse.

  6. Hepatocyte overexpression of GPC3 suppresses hepatocyte proliferation and liver regeneration and alters gene expression profiles.

  7. glypican-3 is involved in the recruitment of M2-polarized tumor-associated macrophages in hepatocellular carcinoma

  8. GPC3 inhibits the PI3K/Akt (Montrer AKT1 Anticorps) anti-apoptotic pathway while it stimulates the p38MAPK (Montrer MAPK14 Anticorps) stress-activated one in murine mammary adenocarcinoma LM3 cells

  9. Gpc3 function in development of Simpson-Golabi-Behmel syndrome is IGF-independent

  10. GPC3 knockout mice exhibit alterations in the Wnt (Montrer WNT2 Anticorps) signaling pathway, which is also associated with the regulation of cell proliferation

Glypican 3 (GPC3) profil antigène

Antigen Summary

Cell surface heparan sulfate proteoglycans are composed of a membrane-associated protein core substituted with a variable number of heparan sulfate chains. Members of the glypican-related integral membrane proteoglycan family (GRIPS) contain a core protein anchored to the cytoplasmic membrane via a glycosyl phosphatidylinositol linkage. These proteins may play a role in the control of cell division and growth regulation. The protein encoded by this gene can bind to and inhibit the dipeptidyl peptidase activity of CD26, and it can induce apoptosis in certain cell types. Deletion mutations in this gene are associated with Simpson-Golabi-Behmel syndrome, also known as Simpson dysmorphia syndrome. Alternative splicing results in multiple transcript variants.

Alternative names and synonyms associated with Glypican 3 (GPC3)

  • glypican 3 (gpc3) anticorps
  • glypican 3 (GPC3) anticorps
  • glypican 3 (Gpc3) anticorps
  • DGSX anticorps
  • Glypican-3 anticorps
  • GPC3 anticorps
  • GTR2-2 anticorps
  • MXR7 anticorps
  • OCI-5 anticorps
  • SDYS anticorps
  • SGB anticorps
  • SGBS anticorps
  • SGBS1 anticorps

Protein level used designations for anti-Glypican 3 (GPC3) Anticorps

glypican 3 , glypican-3-like , glypican proteoglycan 3 , glypican-3 , heparan sulphate proteoglycan , intestinal protein OCI-5 , secreted glypican-3 , defective in Simpson-Golabi-Behmel overgrowth syndrome , proteoglycan GPC3 , Intestinal protein OCI-5

GENE ID SPECIES
387365 Danio rerio
706773 Macaca mulatta
100023253 Monodelphis domestica
100135027 Xenopus (Silurana) tropicalis
100401118 Callithrix jacchus
100444952 Pongo abelii
100477314 Ailuropoda melanoleuca
100548246 Meleagris gallopavo
100591673 Nomascus leucogenys
2719 Homo sapiens
481056 Canis lupus familiaris
615239 Bos taurus
14734 Mus musculus
25236 Rattus norvegicus
100351858 Oryctolagus cuniculus
100726246 Cavia porcellus
100516171 Sus scrofa
770863 Gallus gallus
101119285 Ovis aries
465866 Pan troglodytes
Fournisseurs de qualité sélectionnés pour anti-Glypican 3 (GPC3) Anticorps
Avez-vous cherché autre chose?